SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-026564
Filing Date
2019-02-04
Accepted
2019-02-04 09:34:03
Documents
2
Period of Report
2019-02-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d666781d8k.htm 8-K 22535
2 EX-99.1 d666781dex991.htm EX-99.1 23091
  Complete submission text file 0001193125-19-026564.txt   46985
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35405 | Film No.: 19561851
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences